In a regulatory filing, Karuna Therapeutics (KRTX) said the company is "aware of media reports indicating the closure of Silicon Valley Bank, or ‘SVB,’ and the appointment of the Federal Deposit Insurance Corporation as receiver. The company maintains a de minimis amount of cash and cash equivalents, less than one million U.S. dollars in excess of the FDIC standard deposit insurance limit, with SVB."
Published first on TheFly
See the top stocks recommended by analysts >>
Read More on KRTX:
- Karuna initiated with Neutral, $214 target at Cantor Fitzgerald
- Karuna Therapeutics initiated with a Neutral at Cantor Fitzgerald
- Karuna Therapeutics price target lowered to $257 from $262 at Wells Fargo
- Karuna Therapeutics reports Q4 EPS ($2.22), consensus ($2.25)
- Karuna Therapeutics signing exclusive global license agreement for TRPC4/5